Monday, August 9, 2021

Jerusalem Post

COVID: 90% of patients treated with new Israeli drug discharged in 5 days

The Phase II trial for an Israeli COVID drug saw some 29 out of 30 patients, moderate to serious, recover within a few days.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)